Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... of a therapeutic vaccine for Hepatitis C, and from the National Institute of Allergy and Infectious Diseases (via the University of New Mexico) for the development of a prophylactic ... of New Mexico) for the development of a prophylactic vaccine against the bio-terror agent that causes tularemia. Aduro will use the new capital to complete the ...
2009 NOV 23 ... Chemotherapy, Clinical Research, Clinical Trial Research, Drug Therapy, Immunotherapy, Infectious Disease, Lung Neoplasms, Non-Small Cell Lung Cancer, Non-Small Cell Lung Carcinoma, ... survival. ASCI is an investigational class of cancer immunotherapy agent aimed at educating the patient's immune system to identify cancer cells in a specific ...
2009 NOV 23 ... The Company has a broad research pipeline encompassing many therapeutic areas including infectious disease and renal disease, among others. Its lead development candidate is the HIV ... of CTP-518 to maintain acceptable therapeutic blood concentrations without a boosting agent such as ritonavir. It will also be used to determine doses for subsequent studies in ...
2009 NOV 23 ... Clinical Trial Research, Drug Development, Drug Resistance, Drug Therapy, Hormones, Infectious Disease, Lung Neoplasms, Oncology, Pulmonology, Respiratory Infection, Small Cell Lung ... cancer tumours. They tested the drug on its own and alongside the standard chemotherapy agent cisplatin, which is frequently used to treat patients with the disease. In the first ...
2009 NOV 28 ... a biopharmaceutical company focused on developing products to treat and prevent serious infectious diseases. In addition to FV-100 and INX-189, the Company has licensed the use of its ... VZV, and can inhibit its replication substantially faster than any other antiviral agent currently approved for the treatment of shingles. Inhibitex believes these ...
2009 NOV 23 ... Antioxidant, Chemotherapy, Cisplatin, Drug Therapy, Drugs, Free Radical Scavenger, Infectious Disease, Lung Neoplasms, Melatonin, Non-Small Cell Lung Cancer, Non-Small Cell Lung ... of China, "Accumulating studies indicate that melatonin is a natural oncostatic agent capable of mediating the influence of the psychoneuroendocrine system on cancer growth. ...
2009 NOV 23 ... "Pneumonia, along with influenza, is the leading cause of mortality associated with infectious diseases in the USA. Tigecycline is a novel antimicrobial agent that is active against a ...
2009 NOV 23 ... Microbiology, Community-Acquired, Drug Development, Drug Resistance, Epidemiology, Infectious Disease, Neurology, Pharmaceuticals, Pneumococcal, Pneumonia, Pulmonology, Respiratory ... collected from May 2003 through October 2004. The strains were tested for antimicrobial agent susceptibility, serotype and genotype by multilocus sequence typing (MLST) and the ...
2009 NOV 23 ... For additional information, contact J.B. Bliska, SUNY Stony Brook, Center Infectious Disease, Stony Brook, NY 11794, USA. Publisher contact information for the ... According to recent research from the United States, "Yersinia pestis, the agent of plague, uses a type III secretion injectisome to deliver Yop proteins into ...
2009 NOV 23 ... Chemotherapy, Drug Therapy, Drugs, Gynecologic Cancer, Gynecology, Hypersensitivity, Infectious Disease, Lung Cancer, Lung Neoplasms, Oncology, Paclitaxel, Pharmaceuticals, ... malignancies. It is solubilized in Cremophor EL, a polyoxyethylated castor oil agent responsible for the high rate of paclitaxel-associated hypersensitivity reactions." ...
2009 NOV 23 ... "Infectious complications are one of the most frequent and feared adverse medical events in ... monitoring with medical management in the intensive care setting until the causative agent is found and eradicated." Negretepulido and colleagues published their ...
2009 NOV 23 ... Biotechnology, Chromatography, Clinical Trial Research, Diagnosis, Diagnostics, Drugs, Infectious Disease, Pharmaceuticals, Pharmacokinetics, Pulmonology, Respiratory Infection, Therapy, ... "2-Methoxyestradiol is currently in phase II clinical trials as a chemotherapeutic agent. An LC method with fluorescence detection was developed for determination of ...
2009 NOV 23 ... De and colleagues published their study in European Journal of Clinical Microbiology & Infectious Diseases (Simultaneous detection of human bocavirus and adenovirus by multiplex ... (RSV), human metapneumovirus (hMPV) and influenza A virus were investigated. A viral agent was detected in 61% (n=272/445) of the NPAs. Multiplex Q-PCR found a prevalence of 11% ...
2009 NOV 19 ... 15-20% of community-acquired pneumonia cases in pregnancy. Recent recommendations by the Infectious Diseases Society of America and the American Thoracic Society on the management of ... viral and fungal pathogens all cause pneumonia in pregnancy, although the causative agent is identified in only 40-60% of cases. The most common single pathogen is Streptococcus ...
